Meningioma medroxyprogesterone feasibility assessment in the IDA Germany and IMRD UK databases

Study type

• Study topic:
  Disease /health condition
• Study type:
  Non-interventional study
• Scope of the study:
  Feasibility analysis

Non-interventional study

• Non-interventional study design:
  Cohort

Study drug and medical condition

• Medicinal product name, other:
  Progesterone
• Medical condition to be studied:
  Meningioma

Population studied

• Short description of the study population:
  General female population
• Age groups:
  • Paediatric Population (< 18 years)

    • Infants and toddlers (28 days – 23 months)
    • Children (2 to < 12 years)
    • Adolescents (12 to < 18 years)
  • Adult and elderly population (≥18 years)

    • Adults (18 to < 65 years)

      • Adults (18 to < 46 years)
      • Adults (46 to < 65 years)
    • Elderly (≥ 65 years)

      • Adults (65 to < 75 years)
      • Adults (75 to < 85 years)
      • Adults (85 years and over)

Study design details

• Study design:
  Descriptive cohort study
• Main study objective:
  To described medroxyprogesterone in women according to dose and age and prior history of meningioma.;
• Setting:
  Primary care electronic health records